Latest Breaking News On - Spurwing communications - Page 1 : vimarsana.com

ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for

SAN MATEO, Calif. and SINGAPORE, April 24, 2024 (GLOBE NEWSWIRE) ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today

United statesSan diegoEmma thompsonAshleyr robinsonFerda cevikbasSpurwing communicationsAmerican thoracic society international conferencePharmaceuticals nasdaqBronchial airway constrictionLifesci advisorsChronic obstructive pulmonary diseaseThoracic society international conferenceEblasakimab significantly alleviatesDerived lung slicesTranslational scienceSan mateo

ASLAN PHARMACEUTICALS : ANNOUNCES POSITIVE INTERIM RESULTS FROM PHASE 2 STUDY OF EBLASAKIMAB IN DUPILUMAB-EXPERIENCED ATOPIC DERMATITIS PATIENTS - Form 6-K

ASLAN PHARMACEUTICALS ANNOUNCES POSITIVE INTERIM RESULTS FROM PHASE 2 STUDY OF EBLASAKIMAB IN DUPILUMAB-EXPERIENCED ATOPIC DERMATITIS PATIENTS - Interim readout.

United statesCarl firthEmma thompsonAshleyr robinsonCompany us securitiesSpurwing communicationsPharmaceuticals nasdaqCompany annual report on formCommission file noExchange commissionExchange commission onLifesci advisorsEczema area severity indexChief executive officerNorth americaInvestigator global assessment

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice - April 19, 2024

SAN MATEO, Calif. and SINGAPORE - ASLAN Pharmaceuticals , a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today.

United statesEmma thompsonAshleyr robinsonLetter for the companySpurwing communicationsCompany annual report on formExchange commissionPharmaceuticals nasdaqCompany formCommission file noCompany american depositaryLifesci advisorsNasdaq stock marketNasdaq listing ruleNasdaq capital marketStockholder equity requirement

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice

SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused b.

United statesEmma thompsonAshleyr robinsonLetter for the companyCommission file noCompany american depositaryExchange commission onExchange commissionLifesci advisorsCompany us securitiesPharmaceuticals nasdaqSpurwing communicationsCompany annual report on formCompany formNasdaq stock marketNasdaq listing rule

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEmma thompsonAshleyr robinsonCompany formLetter for the companyCompany us securitiesCompany american depositaryLifesci advisorsCommission file noExchange commissionSpurwing communicationsCompany annual report on formExchange commission onPharmaceuticals nasdaqNasdaq stock marketNasdaq listing rule